Because no treatment has been documented to be effective for SARS, scientists from the Centers for Disease Control and Prevention, the National Institutes of Health, the Defense Department and the pharmaceutical industry met this week to work on identifying any known or experimental drugs that might be effective.
Natalizumab is currently not documented to be effective against CIS, SPMS or PPMS.
Fingolimod is currently not documented to be effective against CIS, SPMS or PPMS.
To prevent development of hypertension and proteinuria, ACE inhibition has been documented to be effective even in normotensive diabetic women with microalbuminuria (7).
In the absence of treatment, the condition is often fatal, although expensive and successful treatment options are available and have recently been documented to be effective (2 ).
Furthermore, RNA interference-mediated gene silencing has recently been documented to be effective in P. superbus and the parthenogenetic Panagrolaimus strain PS1162 [ 38].
Provider referral has been documented to be effective in identifying sexual partners at risk in developed countries [ 7, 38, 39], and is generally permitted as a supplement to patient referral in North America [ 40] and Europe [ 41, 42].
Thus, it seems that only SPMS patients with superimposed relapses benefit from interferon beta treatment 15– 18. Interferons have not been documented to be effective in primary progressive MS (PPMS) 19.
The technique has well documented to be effective and safe for treating multilevel CSM resulting in less intraoperative blood loss, shorter operative times and shorter hospital stays for patients [ 21, 38].
These documents have been shown to be effective for patient information [ 10, 11], but are not detailed enough for physicians.
